Iron deficiency and new insights into therapy

Michael SY Low and George Grigoriadis
Med J Aust 2017; 207 (2): . || doi: 10.5694/mja16.01304
Published online: 17 July 2017



  • Iron deficiency and iron deficiency anaemia remain prevalent in Australia.
  • The groups at highest risk are pre-menopausal women, socially disadvantaged people and those of Indigenous background.
  • Diagnosing iron deficiency using a full blood examination and iron studies can be difficult and can be further complicated by concomitant inflammation. Results of iron studies should always be interpreted as an overall picture rather than focusing on individual parameters. In difficult clinical scenarios, soluble transferrin receptor assays can be useful.
  • Management of iron deficiency involves identification and treatment of the cause of iron deficiency, as well as effective iron replacement.
  • Clinicians should always take a detailed history and perform a comprehensive physical examination of a patient with iron deficiency. Patients should be monitored even if a likely cause of iron deficiency is identified.
  • Patients who fail to respond to iron replacement or maintain iron status should be referred for further investigation, including endoscopy to exclude internal bleeding.
  • Both enteral and parenteral iron are effective at replacing iron. For most adult patients, we recommend trialling daily oral iron (30–100 mg of elemental iron) as the first-line therapy.
  • Safety and efficacy of intravenous iron infusions have improved with the availability of a newer formulation, ferric carboxymaltose. Patients who fail to respond to oral iron replacement can be safely managed with intravenous iron.
  • Blood transfusion for iron deficiency anaemia should be reserved for life-threatening situations and should always be followed by appropriate iron replacement.


  • 1 Monash Health, Melbourne, VIC
  • 2 Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC
  • 3 Monash University, Melbourne, VIC


Michael Low is employed by Monash Health and funded by a Royal Australasian College of Physicians (RACP) National Health and Medical Research Council (NHMRC) CRB Blackburn Scholarship. George Grigoriadis is employed by Monash Health and Alfred Health and funded by a Victorian Cancer Agency Clinical Research Fellowship. We thank Shahla Vilcassim (Monash Haematology) for her help in attaining the figure in .

Competing interests:

No relevant disclosures.

  • 1. Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health 2013; 1: e16-e25.
  • 2. Stoltzfus R. Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr 2001; 131 (2S-2): 565S-567S.
  • 3. Pasricha SR, Flecknoe-Brown SC, Allen KJ, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2010; 193: 525-532. <MJA full text>
  • 4. Hopkins RM, Gracey MS, Hobbs RP, et al. The prevalence of hookworm infection, iron deficiency and anaemia in an Aboriginal community in north-west Australia. Med J Aust 1997; 166: 241-244.
  • 5. Callander EJ, Schofield DJ. Is there a mismatch between who gets iron supplementation and who needs it? A cross-sectional study of iron supplements, iron deficiency anaemia and socio-economic status in Australia. Br J Nutr 2016; 115: 703-708.
  • 6. Salvin HE, Pasricha SR, Marks DC, Speedy J. Iron deficiency in blood donors: a national cross-sectional study. Transfusion 2014; 54: 2434-2444.
  • 7. Digestive Health Foundation, Gastroenterological Society of Australia. Iron deficiency: clinical update. Melbourne: GESA, 2015. (accessed May 2017).
  • 8. Beard JL. Why iron deficiency is important in infant development. J Nutr 2008; 138: 2534-2536.
  • 9. World Health Organization. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Geneva: WHO, 2001. (accessed May 2017).
  • 10. Low MS, Speedy J, Styles CE, et al. Daily iron supplementation for improving anaemia, iron status and health in menstruating women. Cochrane Database Syst Rev 2016; (4): CD009747.
  • 11. Breymann C. Iron deficiency anemia in pregnancy. Semin Hematol 2015; 52: 339-347.
  • 12. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet 2016; 387: 907-916.
  • 13. Worwood M. Annex 2. Indicators of the iron status of populations: ferritin. In: Assessing the iron status of populations. 2nd ed. Geneva: World Health Organization and Centers for Disease Control and Prevention, 2007: 31-74.
  • 14. Garcia-Casal MN, Peña-Rosas JP, Pasricha SR. Rethinking ferritin cutoffs for iron deficiency and overload. Lancet Haematol 2014; 1: e92-e94.
  • 15. Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr 2015; 102: 1585-1594.
  • 16. Dugdale AE. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2011; 194: 429. <MJA full text>
  • 17. Tan YL, Kidson-Gerber G. Antenatal haemoglobinopathy screening in Australia. Med J Aust 2016; 204: 226-230. <MJA full text>
  • 18. Infusino I, Braga F, Dolci A, Panteghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol 2012; 138: 642-649.
  • 19. World Health Organization. Guideline: daily iron supplementation in adult women and adolescent girls. Geneva: WHO, 2016. (accessed May 2017).
  • 20. Pasricha SR, Drakesmith H. Iron deficiency anemia: problems in diagnosis and prevention at the population level. Hematol Oncol Clin North Am 2016; 30: 309-325.
  • 21. Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367: 133-143.
  • 22. Tielsch JM, Khatry SK, Stoltzfus RJ, et al. Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial. Lancet 2006; 367: 144-152.
  • 23. Thompson J, Biggs BA, Pasricha SR. Effects of daily iron supplementation in 2- to 5-year-old children: systematic review and meta-analysis. Pediatrics 2013; 131: 739-753.
  • 24. Pasricha SR, Hayes E, Kalumba K, Biggs BA. Effect of daily iron supplementation on health in children aged 4–23 months: a systematic review and meta-analysis of randomised controlled trials. Lancet Glob Health 2013; 1: e77-e86.
  • 25. Low M, Farrell A, Biggs BA, Pasricha SR. Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials. CMAJ 2013; 185: E791-E802.
  • 26. Pasricha SR, Low M, Thompson J, et al. Iron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysis. J Nutr 2014; 144: 906-914.
  • 27. Higgins JPT, Green S, editors. Section 12.2. Assessing the quality of a body of evidence. In: Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. (accessed May 2017).
  • 28. Fernández-Gaxiola AC, De-Regil LM. Intermittent iron supplementation for reducing anaemia and its associated impairments in menstruating women. Cochrane Database Syst Rev 2011; (12): CD009218.
  • 29. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015; 126: 1981-1989.
  • 30. Rognoni C, Venturini S, Meregaglia M, et al. Efficacy and safety of ferric carboxymaltose and other formulations in iron-deficient patients: a systematic review and network meta-analysis of randomised controlled trials. Clin Drug Investig 2016; 36: 177-194.
  • 31. Onken JE, Bregman DB, Harrington RA, et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion 2014; 54: 306-315.
  • 32. Schatz U, Arneth B, Siegert G, et al. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations. Atheroscler Suppl 2013; 14: 115-122.
  • 33. Chunilal S, Paricha S, Bennett A, et al. Safety of RAPid INJECTion of undiluted ferric carboxymaltose to patients with iron deficiency anaemia (RAPINJECT) [abstract]. Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, 13–16 November 2016. Melbourne.
  • 34. Bregman DB, Goodnough LT. Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia. Ther Adv Hematol 2014; 5: 48-60.
  • 35. Onken JE, Bregman DB, Harrington RA, et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant 2014; 29: 833-842.
  • 36. Porter JB. Practical management of iron overload. Br J Haematol 2001; 115: 239-252.
  • 37. Australian Red Cross Blood Service. Classification & incidence of adverse events. (accessed May 2017).
  • 38. Anonymous. Iron deficiency anaemia in a young woman: a plea for early investigation. Med J Aust 2013; 198: 562. <MJA full text>
  • 39. The Royal Children’s Hospital Melbourne. Iron preparations and therapy. Iron supplementation. (accessed May 2017).
  • 40. Laass MW, Straub S, Chainey S, et al. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol 2014; 14: 184.
  • 41. Chang TP, Rangan C. Iron poisoning: a literature-based review of epidemiology, diagnosis, and management. Pediatr Emerg Care 2011; 27: 978-985.
  • 42. Dewey KG. Impact of breastfeeding on maternal nutritional status. Adv Exp Med Biol 2004; 554: 91-100.
  • 43. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Routine antenatal assessment in the absence of pregnancy complications (C-OBS 03B). 2016. (accessed May 2017).
  • 44. Burke RM, Leon JS, Suchdev PS. Identification, prevention and treatment of iron deficiency during the first 1000 days. Nutrients 2014; 6: 4093-4114.
  • 45. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015; (7): CD004736.
  • 46. Peña-Rosas JP, De-Regil LM, Gomez Malave H, et al. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015; (10): CD009997.
  • 47. Breymann C, Milman N, Mezzacasa A, et al. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med 2016; doi: 10.1515/jpm-2016-0050 [Epub ahead of print].
  • 48. Hallet J, Hanif A, Callum J, et al. The impact of perioperative iron on the use of red blood cell transfusions in gastrointestinal surgery: a systematic review and meta-analysis. Transfus Med Rev 2014; 28: 205-211.
  • 49. Froessler B, Palm P, Weber I, et al. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg 2016; 264: 41-46.
  • 50. Khalafallah AA, Yan C, Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol 2016; 3: e415-e425.
  • 51. Elhenawy AM, Meyer SR, Bagshaw SM, et al. Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis. Syst Rev 2015; 4: 29.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.